Delayed Prostate Cancer Therapy Alexandria VA

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

STE 400
(703) 280-5390
8503 Arlington Blvd
Fairfax, VA
Business
Fairfax Northern Virginia Hematology & Oncolo
Specialties
Oncology

Data Provided by:
Stephen Joshua M Banks, MD
(703) 504-7900
4320 Seminary Rd
Alexandria, VA
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Stanford Univ Sch Of Med, Stanford Ca 94305
Graduation Year: 1993

Data Provided by:
Jane Grayson, MD
(703) 504-7900
4320 Seminary Rd
Alexandria, VA
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Female
Education
Medical School: Harvard Med Sch, Boston Ma 02115
Graduation Year: 1973
Hospital
Hospital: Inova Alexandria Hospital, Alexandria, Va
Group Practice: Inova Alexandria Cancer Ctr

Data Provided by:
Peter Francis
(703) 823-5322
4660 Kenmore Ave
Alexandria, VA
Specialty
Medical Oncology

Data Provided by:
Jane Grayson
(703) 504-7900
4320 Seminary Rd
Alexandria, VA
Specialty
Radiation Oncology

Data Provided by:
Winston Mizuo Ueno, MD
(703) 823-5322
4660 Kenmore Ave Ste 1018
Alexandria, VA
Specialties
Oncology (Cancer), Hematology-Internal Medicine
Gender
Male
Education
Medical School: Creighton Univ Sch Of Med, Omaha Ne 68178
Graduation Year: 1966
Hospital
Hospital: Inova Alexandria Hospital, Alexandria, Va
Group Practice: Fairfax Northern Virginia Hematology Oncology Alexandria

Data Provided by:
Peter Francis, MD
(703) 823-5322
4660 Kenmore Ave Ste 1018
Alexandria, VA
Specialties
Oncology (Cancer), Infectious Diseases
Gender
Male
Education
Medical School: New York Univ Sch Of Med, New York Ny 10016
Graduation Year: 1985

Data Provided by:
Daniel Hugh Clarke, MD
(703) 504-7900
4320 Seminary Rd
Alexandria, VA
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Med Coll Of Ga Sch Of Med, Augusta Ga 30912
Graduation Year: 1978

Data Provided by:
Matthew M Poggi
(703) 504-7900
4320 Seminary Rd
Alexandria, VA
Specialty
Radiation Oncology

Data Provided by:
Robert F Dobrzynski, MD
(703) 379-9111
3970 Fort Worth Ave
Alexandria, VA
Specialties
Internal Medicine, Medical Oncology
Gender
Male
Education
Medical School: Georgetown Univ Sch Of Med, Washington Dc 20007
Graduation Year: 1969
Hospital
Hospital: Inova Fairfax Hospital, Falls Church, Va; Inova Alexandria Hospital, Alexandria, Va
Group Practice: Hemotology-Oncology Assoc Ltd

Data Provided by:
Data Provided by:

Delayed Prostate Cancer Therapy

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com